首页 › 基金 › DEERFIELD MANAGEMENT COMPANY, L.P. › STOK
DEERFIELD MANAGEMENT COMPANY, L.P. 对 STOK 的持仓历史
STOKE THERAPEUTICS INC · 医疗保健
DEERFIELD MANAGEMENT COMPANY, L.P. 在 Q2 2026 的 13F 申报中披露持有 STOK(STOKE THERAPEUTICS INC)1,823,500 股,市值约 US$59.7M,约占其申报组合的 0.75%,在其申报持仓中市值排名第 36 位。 DEERFIELD MANAGEMENT COMPANY, L.P. 最近 3 个申报季度中有 3 个季度披露了 STOK 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
DEERFIELD MANAGEMENT COMPANY, L.P. 对 STOK 的持仓演变
DEERFIELD MANAGEMENT COMPANY, L.P. 于 Q4 2025 首次披露 STOK 持仓:1,823,500 股(约 US$57.9M)。 该持仓在 Q2 2026 达到峰值 1,823,500 股,市值约 US$59.7M。 在 3 次申报中,DEERFIELD MANAGEMENT COMPANY, L.P. 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 1,823,500 股、市值约 US$59.7M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 1.82M | $57.88M | 新进 |
| Q1 2026 | 1.82M | $59.37M | 持有 |
| Q2 2026 | 1.82M | $59.66M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 STOK 与 13F 数据
STOK(STOKE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 52 只申报持有 STOK,申报仓位最大的包括:RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 STOK 的基金
- RTW INVESTMENTS, LP 5.62M 股 · $184.00M · Q2 2026
- Lynx1 Capital Management LP 4.04M 股 · $132.14M · Q2 2026
- Redmile Group, LLC 3.95M 股 · $129.11M · Q2 2026
- BAKER BROS. ADVISORS LP 3.34M 股 · $109.18M · Q2 2026
- TORONTO DOMINION BANK 3.17M 股 · $103.83M · Q2 2026
- BVF INC/IL 2.55M 股 · $83.36M · Q2 2026
- Siren, L.L.C. 2.00M 股 · $65.29M · Q2 2026
- EcoR1 Capital, LLC 735.00K 股 · $24.05M · Q2 2026
- MPM BioImpact LLC 723.31K 股 · $23.67M · Q2 2026
- Opaleye Management Inc. 700.00K 股 · $22.90M · Q2 2026
- Troluce Capital Advisors LLC 496.42K 股 · $16.24M · Q2 2026
- Granahan Investment Management, LLC 461.61K 股 · $15.10M · Q2 2026
更多关于 DEERFIELD MANAGEMENT COMPANY, L.P.
常见问题
How long has DEERFIELD MANAGEMENT COMPANY, L.P. held STOK?
DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed STOK holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in STOK?
As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 1.82M shares of STOK (STOKE THERAPEUTICS INC), valued at $59.66M, representing 0.75% of its reported portfolio and ranking #36.
Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling STOK?
In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. held unchanged its position in STOK. The position peaked in Q2 2026 at 1.82M shares.
Which other funds hold STOK?
Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.